Novo nordisk tests new approach to reduce side effects in obesity drug trial
NCT ID NCT06718998
Summary
This study is testing different ways to increase the dose of an experimental weight management medication called NNC0519-0130. Researchers want to see if certain dosing methods can reduce side effects that might occur when people take the medication. The 24-week study involves 114 overweight or obese participants who will be randomly assigned to one of four different dose escalation approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Graz
RECRUITINGGraz, 8010, Austria
Conditions
Explore the condition pages connected to this study.